The Asia Pacific Pediatric Association (APPA) position statement on the MAFLD definition of fatty liver disease
- PMID: 37051073
- PMCID: PMC10084573
- DOI: 10.1177/20406223231164523
The Asia Pacific Pediatric Association (APPA) position statement on the MAFLD definition of fatty liver disease
Keywords: APPA; Fatty liver disease; MAFLD; NAFLD; children.
Conflict of interest statement
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
References
-
- Eslam M, Alkhouri N, Vajro P, et al.. Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement. Lancet Gastroenterol Hepatol 2021; 6: 864–873. - PubMed
-
- Eslam M, Newsome PN, Sarin SK, et al.. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol 2020; 73: 202–209. - PubMed
-
- Eslam M, Sanyal AJ, George J, et al.. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 2020; 158: 1999–2014. - PubMed
-
- Méndez-Sánchez N, Bugianesi E, Gish RG, et al.. Global multi-stakeholder endorsement of the MAFLD definition. Lancet Gaseroenterol Hepatol 2022; 7: 388–390. - PubMed
-
- El-Shabrawi M, Memon I, Attia D, et al.. The International Society of Tropical Paediatrics (ISTP) endorses the redefinition of fatty liver disease. J Hepatol 2022; 76: 738–739. - PubMed
LinkOut - more resources
Full Text Sources
